| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8c14549023aea04d72fe633b7bb0fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a34821cf27f040015af94604304a5014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cb07f94d8abcff982bde66ea58d0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a0cfeaac1ec63665873a5bb752fa8df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_992d8e2b644ab21260ad23fb868613b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07ca23be673db0b264d00c42c7eaa074 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65b1689de30675ab44e4b4f8589111e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08e9f85e5566629301acce7488e9ea36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb518826087a9a14b2aedae5f8c01a55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_599d14cb3302eb5c71a9c7c9e93c048a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9962eade013f45c83c621cbed01e1ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f61237b503ee78d561d02c63a591a64 |
| publicationDate |
2007-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007013946-A2 |
| titleOfInvention |
Method of predicting responsiveness to chemotherapy and selecting treatments |
| abstract |
Methods are provided for predicting responsiveness of cancer cells to chemotherapy by measuring the level of phosphorylated Stat or the level of expression of Survivin in a cancer and comparing the level in the cancer cell to the respective level in a control. Also provided are methods of selecting a chemotherapeutic treatment for a subject diagnosed with cancer by measuring the level of phosphorylated Stat or the level of expression of Survivin in a cancer and comparing the level in the cancer cell to the respective level in a control. Kits for performing the methods are also provided. Methods for modulating Survivin-dependent apoptosis in a cancer cell are also disclosed. |
| priorityDate |
2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |